Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jul 23, 2026
144 Jul 23, 2026
144 Jul 23, 2026
144 Jul 23, 2026
424B2 Jun 17, 2026 424B2
8-K Jun 16, 2026 8-K
8-K Jun 16, 2026 8-K
EFFECT Jun 15, 2026
CORRESP Jun 11, 2026
UPLOAD Jun 10, 2026
S-3 Jun 5, 2026 S-3
SCHEDULE 13D/A May 20, 2026
4 May 20, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
S-8 May 14, 2026 S-8
SCHEDULE 13G/A May 13, 2026
SCHEDULE 13G May 13, 2026
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
← Newer Page 2 of 43 · 1060 filings Older →